Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes by Retrospective Eligibility for Maintenance Therapy of Patients With Advanced Urothelial Carcinoma: Post Hoc Analysis of the Phase 3 KEYNOTE-361 Trial.
Mamtani R, Matsubara N, Pino AM, Herranz UA, Şendur MAN, Gravis G, Huillard O, Lee HJ, Gafanov R, Joly F, Bedke J, Sella A, Chang YH, Imai K, Moreno BH, Xu JZ, Alva A, Powles T. Mamtani R, et al. Among authors: joly f. Clin Genitourin Cancer. 2024 Oct 28;23(1):102248. doi: 10.1016/j.clgc.2024.102248. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39579409 Free article.
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial.
Classe JM, Meeus P, Hudry D, Wernert R, Quenet F, Marchal F, Houvenaeghel G, Bats AS, Lecuru F, Ferron G, Brigand C, Berton D, Gladieff L, Joly F, Ray-Coquard I, Durand-Fontanier S, Liberale G, Pocard M, Georgeac C, Gouy S, Guilloit JM, Guyon F, Costan C, Rousselet JM, de Guerké L, Bakrin N, Brument E, Martin E, Asselain B, Campion L, Glehen O; UNICANCER/CHIPOR Investigators. Classe JM, et al. Among authors: joly f. Lancet Oncol. 2024 Nov 13:S1470-2045(24)00531-X. doi: 10.1016/S1470-2045(24)00531-X. Online ahead of print. Lancet Oncol. 2024. PMID: 39549720
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.
Francis KE, Simon S, Gebski V, Joly F, Ledermann JA, Penson RT, Oza AM, Korach J, Lainez N, Cecere SC, Tasca G, Gropp-Meier M, Fujiwara K, Lowe ES, Friedlander M, Pujade-Lauraine E, Lee CK. Francis KE, et al. Among authors: joly f. Gynecol Oncol. 2024 Nov 12;192:50-55. doi: 10.1016/j.ygyno.2024.11.004. Online ahead of print. Gynecol Oncol. 2024. PMID: 39536691 Free article.
Tumor-intrinsic chemosensitivity assessed by KELIM and prognosis by BRCA status in patients with advanced ovarian carcinomas.
Becker O, Durand A, Chevrier M, Collet L, Gladieff L, Joly F, Sauterey B, Pomel C, Costaz H, Pautier P, Guillemet C, de la Motte Rouge T, Sabatier R, Classe JM, Petit T, Leblanc E, Marchal F, Colombo PE, Barranger E, Savoye AM, Bosquet L, Ray-Coquard I, Carton M, Colomban O, You B, Rodrigues M. Becker O, et al. Among authors: joly f. Int J Gynecol Cancer. 2024 Oct 31:ijgc-2024-005815. doi: 10.1136/ijgc-2024-005815. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 39481880
Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon-in-continuity: A multicenter, open-label, metabolic balance study.
Verbiest A, Hvistendahl MK, Bolognani F, Li C, Youssef NN, Huh S, Menys A, Bhatnagar G, Vanslembrouck R, Peeters R, Sartoris R, Vermeersch P, Wauters L, Verbeke K, Jeppesen PB, Joly F, Vanuytsel T. Verbiest A, et al. Among authors: joly f. Clin Nutr. 2024 Oct 16;43(12):158-166. doi: 10.1016/j.clnu.2024.10.011. Online ahead of print. Clin Nutr. 2024. PMID: 39461299 Free article.
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey.
Benech N, Cassir N, Alric L, Barbut F, Batista R, Bleibtreu A, Briot T, Davido B, Galperine T, Joly AC, Kapel N, Melchior C, Mosca A, Nebbad B, Pigneur B, Schneider SM, Wasiak M, Scanzi J, Sokol H; French Faecal Transplant Group (GFTF). Benech N, et al. Aliment Pharmacol Ther. 2024 Oct 10. doi: 10.1111/apt.18330. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39387234
Corrigendum to "Operational recommendations for the implementation of home parenteral nutrition program of care according to the guidelines of the European society for clinical nutrition and metabolism" [Clin Nutr ESPEN 63 (2024) 668-675].
Pironi L, Cuerda C, Jeppesen PB, Joly F, Lal S, Lamprecht G, Mundi MS, Szczepanek K, Gossum AV, Vanuytsel T, Wanten G, Weimann A, Bischoff SC. Pironi L, et al. Among authors: joly f. Clin Nutr ESPEN. 2024 Oct 10;64:202. doi: 10.1016/j.clnesp.2024.09.028. Online ahead of print. Clin Nutr ESPEN. 2024. PMID: 39392760 Free article. No abstract available.
FcγR3A polymorphism influences natural killer cell activation and response to anti-PD-L1 (avelumab) in gestational trophoblastic neoplasia.
Msika A, Mathias V, Boudigou M, Chambon M, Dubois V, Hajri T, Lotz JP, Massardier J, Descargues P, Gladieff L, Joly F, Lebreton C, Maucort-Boulch D, Bin S, Rousset P, Allias F, Gaillot-Durand L, Devouassoux-Shisheboran M, Lemaitre N, Alfaidy N, Langlois-Jacques C, Alves-Ferreira M, Golfier F, You B, Thaunat O, Bolze PA, Koenig A. Msika A, et al. Among authors: joly f. Am J Obstet Gynecol. 2024 Oct 5:S0002-9378(24)01046-9. doi: 10.1016/j.ajog.2024.09.115. Online ahead of print. Am J Obstet Gynecol. 2024. PMID: 39370035 Free article.
Long-term behavioral symptom clusters among survivors of early-stage breast cancer. development and validation of a predictive model.
Pagliuca M, Havas J, Thomas E, Drouet Y, Soldato D, Franzoi MA, Ribeiro J, Chiodi CK, Gillanders E, Pistilli B, Menvielle G, Joly F, Lerebours F, Rigal O, Petit T, Giacchetti S, Dalenc F, Wassermann J, Arsene O, Martin AL, Everhard S, Tredan O, Boyault S, De Laurentiis M, Viari A, Deleuze JF, Bertaut A, André F, Vaz-Luis I, Di Meglio A. Pagliuca M, et al. Among authors: joly f. J Natl Cancer Inst. 2024 Sep 9:djae222. doi: 10.1093/jnci/djae222. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39250750
761 results